6-amino-1-hydroxyhexane-1,1-diphosphonate has been researched along with Pain in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al Khayyat, SG; Baldi, C; Bardelli, M; Cantarini, L; Conticini, E; D'Alessandro, R; Falsetti, P; Frediani, B; Gentileschi, S; Nicosia, A | 1 |
| Avanzati, A; Campagna, MS; De Filippo, G; Franci, B; Gennari, L; Gianfrancesco, F; Martini, G; Merlotti, D; Mossetti, G; Nuti, R; Rendina, D; Strazzullo, P | 1 |
| Avanzati, A; De Paola, V; Gennari, L; Martini, G; Merlotti, D; Nuti, R; Valleggi, F | 1 |
| Casciari, C; Cristallini, S; Filipponi, P; Gregorio, F; Policani, G | 1 |
3 trial(s) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Pain
| Article | Year |
|---|---|
Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone.
Topics: Aged; Alkaline Phosphatase; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Infusions, Intravenous; Injections, Intramuscular; Male; Osteitis Deformans; Pain; Quality of Life; Time Factors; Treatment Outcome; Vitamin D | 2011 |
Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone.
Topics: Aged; Diphosphonates; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Imidazoles; Injections, Intravenous; Male; Osteitis Deformans; Pain; Pamidronate; Quality of Life; Time Factors; Zoledronic Acid | 2007 |
Paget's disease of bone: benefits of neridonate as a first treatment and in cases of relapse after clodronate.
Topics: Acute-Phase Reaction; Aged; Aged, 80 and over; Alkaline Phosphatase; Amino Acids; Bone Resorption; Clodronic Acid; Collagen; Collagen Type I; Diphosphonates; Drug Administration Schedule; Drug Resistance; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Osteitis Deformans; Pain; Peptides; Recurrence; Treatment Outcome | 1998 |
1 other study(ies) available for 6-amino-1-hydroxyhexane-1,1-diphosphonate and Pain
| Article | Year |
|---|---|
Efficacy of intravenous neridronate in transient osteoporosis of the hip.
Topics: Acute Disease; Diphosphonates; Female; Humans; Male; Middle Aged; Osteoporosis; Pain; Retrospective Studies | 2022 |